Teladoc (NYSE: TDOC) executive sells shares and receives large equity awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Teladoc Health, Inc. executive Kelly Bliss, President of U.S. Group Health, reported a mix of stock sales and equity awards. Bliss sold 26,647 shares of common stock in an open-market transaction at $5.117 per share to cover tax withholding obligations related to vesting equity awards, and held 84,747 common shares afterward.
On March 1, 2026, Bliss received a grant of 181,661 restricted stock units, each representing a contingent right to one Teladoc share, generally vesting one-third on the first anniversary of the grant date with the balance in eight quarterly installments. Around February 27, 2026, multiple restricted stock unit and performance stock unit awards were exercised or earned, including 27,458 performance stock units determined using metrics tied to Teladoc’s 2025 financial results, all converting to common stock on a one-for-one basis.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 26,647 shares ($136,353)
Net Sell
13 txns
Insider
Bliss Kelly
Role
President, U.S. Group Health
Sold
26,647 shs ($136K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 26,647 | $5.117 | $136K |
| Grant/Award | Restricted Stock Units | 181,661 | $0.00 | -- |
| Exercise | Restricted Stock Units | 3,488 | $0.00 | -- |
| Exercise | Restricted Stock Units | 4,858 | $0.00 | -- |
| Exercise | Restricted Stock Units | 36,610 | $0.00 | -- |
| Exercise | Performance Stock Units | 1,186 | $0.00 | -- |
| Grant/Award | Performance Stock Units | 27,458 | $0.00 | -- |
| Exercise | Performance Stock Units | 5,198 | $0.00 | -- |
| Exercise | Common Stock | 3,488 | $0.00 | -- |
| Exercise | Common Stock | 4,858 | $0.00 | -- |
| Exercise | Common Stock | 36,610 | $0.00 | -- |
| Exercise | Common Stock | 1,186 | $0.00 | -- |
| Exercise | Common Stock | 5,198 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 84,747 shares (Direct);
Restricted Stock Units — 181,661 shares (Direct);
Performance Stock Units — 0 shares (Direct)
Footnotes (1)
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Performance stock units convert to shares of TDOC common stock on a one-for-one basis. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards. On March 3, 2023, the reporting person was granted 41,853 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2024, the reporting person earned 14,263 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. Each performance stock unit represents a contingent right to receive one share of TDOC common stock. Performance award amount determined based on metrics in respect of the issuer's 2025 financial results. The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. On March 1, 2026, the reporting person earned 27,458 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
FAQ
What insider transactions did Kelly Bliss report in Teladoc (TDOC) Form 4?
Kelly Bliss reported one open-market sale of Teladoc common stock and multiple equity award activities. These included exercises and conversions of restricted stock units and performance stock units, as well as new grants that convert into TDOC common shares on a one-for-one basis over future vesting periods.
What new equity awards did Kelly Bliss receive from Teladoc (TDOC)?
Kelly Bliss received 181,661 restricted stock units on March 1, 2026, each representing a contingent right to one Teladoc share. She also earned 27,458 performance stock units tied to 2025 financial metrics, which likewise convert into TDOC common stock on a one-for-one basis as they vest over time.
How do Kelly Bliss’s Teladoc (TDOC) restricted stock units and performance stock units vest?
Her restricted stock units generally vest one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments. Performance stock units vest one-third on March 1, 2026, with the balance also vesting in eight substantially equal quarterly installments thereafter.
How are Teladoc (TDOC) restricted stock units and performance stock units converted for Kelly Bliss?
Each restricted stock unit and each performance stock unit converts into one share of Teladoc common stock. The conversion occurs as the awards vest according to their schedules, creating common share ownership for Kelly Bliss over time as performance conditions and service requirements are satisfied.